Skip to content

Drug interactions

Ticlopidine + Tofacitinib

Severity: Moderate

Ticlopidine and Tofacitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ticlopidine strongly inhibits CYP2C19, a secondary pathway for tofacitinib, which may raise tofacitinib levels. The effect on its own is modest, but it matters more if a CYP3A4 inhibitor is also given.

What this interaction means in plain words

Ticlopidine and Tofacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ticlopidine belongs to Cardiovascular; Tofacitinib belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Ticlopidine inhibits CYP2C19, reducing tofacitinib clearance.

What to do

Monitor for tofacitinib adverse effects such as infection and cytopenias. Reduce the tofacitinib dose if the patient also takes a moderate or strong CYP3A4 inhibitor.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ticlopidine and Tofacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ticlopidine with Tofacitinib?

MediHelp rates the interaction as moderate. Ticlopidine and Tofacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ticlopidine strongly inhibits CYP2C19, a secondary pathway for tofacitinib, which may raise tofacitinib levels. The effect on its own is modest, but it matters more if a CYP3A4 inhibitor is also given.

How serious is the interaction between Ticlopidine and Tofacitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for tofacitinib adverse effects such as infection and cytopenias. Reduce the tofacitinib dose if the patient also takes a moderate or strong CYP3A4 inhibitor.

What other medicines interact with Tofacitinib?

MediHelp also lists interactions of Tofacitinib with, for example, Baricitinib, Cladribine, Upadacitinib. The full list is on the Tofacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in